دورية أكاديمية

Prediction of Normal Tissue Complication Probability (NTCP) After Radiation Therapy Using Imaging and Molecular Biomarkers and Multivariate Modelling.

التفاصيل البيبلوغرافية
العنوان: Prediction of Normal Tissue Complication Probability (NTCP) After Radiation Therapy Using Imaging and Molecular Biomarkers and Multivariate Modelling.
المؤلفون: Alirezaei Z; Medical Physics Department, Isfahan University of Medical Science, Isfahan, Iran., Amouheidari A; Research & Education, Department of Radiation Oncology, Isfahan Milad Hospital, Isfahan, Iran., Iraji S; Medical Physics and Biomedical Engineering Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Hassanpour M; Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran., Hejazi SH; Skin Diseases and Leishmaniosis Research Center, Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran., Davanian F; Radiology Department, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran., Nami MT; Dana Health Center, Shiraz University of Medical Sciences, Shiraz, Iran., Rastaghi S; Biostatistics Department, Mashhad University of Medical Sciences, Mashhad, Iran., Shokrani P; Medical Physics Department, Isfahan University of Medical Science, Isfahan, Iran., Tsien CI; Radiation Oncology Department, Washington University, St. Louis, MO, USA., Nazem-Zadeh MR; Medical Physics and Biomedical Engineering Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. mnazemzadeh@tums.ac.ir.; Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran. mnazemzadeh@tums.ac.ir.
المصدر: Journal of molecular neuroscience : MN [J Mol Neurosci] 2023 Aug; Vol. 73 (7-8), pp. 587-597. Date of Electronic Publication: 2023 Jul 18.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 9002991 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-1166 (Electronic) Linking ISSN: 08958696 NLM ISO Abbreviation: J Mol Neurosci Subsets: MEDLINE
أسماء مطبوعة: Publication: Totowa, NJ : Humana Press
Original Publication: Boston : Birkhäuser [i.e. Cambridge, MA : Birkhäuser Boston, c1989-
مواضيع طبية MeSH: White Matter* , Glioma*/radiotherapy , Glioma*/pathology, Humans ; Diffusion Tensor Imaging/methods ; Quality of Life ; Biomarkers ; Probability ; Necrosis/pathology
مستخلص: The aim of this study was to design a predictive radiobiological model of normal brain tissue in low-grade glioma following radiotherapy based on imaging and molecular biomarkers. Fifteen patients with primary brain tumors prospectively participated in this study and underwent radiation therapy. Magnetic resonance imaging (MRI) was obtained from the patients, including T1- and T2-weighted imaging and diffusion tensor imaging (DTI), and a generalized equivalent dose (gEUD) was calculated. The radiobiological model of the normal tissue complication probability (NTCP) was performed using the variables gEUD; axial diffusivity (AD) and radial diffusivity (RD) of the corpus callosum; and serum protein S100B by univariate and multivariate logistic regression XLIIIrd Sir Peter Freyer Memorial Lecture and Surgical Symposium (2018). Changes in AD, RD, and S100B from baseline up to the 6 months after treatment had an increasing trend and were significant in some time points (P-value < 0.05). The model resulting from RD changes in the 6 months after treatment was significantly more predictable of necrosis than other univariate models. The bivariate model combining RD changes in Gy40 dose-volume and gEUD, as well as the trivariate model obtained using gEUD, RD, and S100B, had a higher predictive value among multivariate models at the sixth month of the treatment. Changes in RD diffusion indices and in serum protein S100B value were used in the early-delayed stage as reliable biomarkers for predicting late-delayed damage (necrosis) caused by radiation in the corpus callosum. Current findings could pave the way for intervention therapies to delay the severity of damage to white matter structures, minimize cognitive impairment, and improve the quality of life of patients with low-grade glioma.
(© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
References: Baumann M, Krause M, Overgaard J, Debus J, Bentzen SM, Daartz J et al (2016) Radiation oncology in the era of precision medicine. Nat Rev Cancer 16(4):234–249. (PMID: 10.1038/nrc.2016.1827009394)
Benedetti F, Poletti S, Hoogenboezem TA, Mazza E, Ambrée O, de Wit H et al (2016) Inflammatory cytokines influence measures of white matter integrity in bipolar disorder. J Affect Disord 202:1–9. (PMID: 10.1016/j.jad.2016.05.04727253210)
Chapman CH, Nazem-Zadeh M, Lee OE, Schipper MJ, Tsien CI, Lawrence TS et al (2013) Regional variation in brain white matter diffusion index changes following chemoradiotherapy: a prospective study using tract-based spatial statistics. PLoS ONE 8(3):e57768. (PMID: 10.1371/journal.pone.0057768234692343587621)
Chapman CH, Zhu T, Nazem-Zadeh M, Tao Y, Buchtel HA, Tsien CI et al (2016) Diffusion tensor imaging predicts cognitive function change following partial brain radiotherapy for low-grade and benign tumors. Radiother Oncol 120(2):234–240. (PMID: 10.1016/j.radonc.2016.06.021274185255003665)
Chintamaneni M, Bhaskar M (2012) Biomarkers in Alzheimer's disease: a review. Int Sch Res Not 2012.
Connor M, Karunamuni R, McDonald C, White N, Pettersson N, Moiseenko V et al (2016) Dose-dependent white matter damage after brain radiotherapy. Radiother Oncol 121(2):209–216. (PMID: 10.1016/j.radonc.2016.10.003277767475136508)
Connor M, Karunamuni R, McDonald C, Seibert T, White N, Moiseenko V et al (2017) Regional susceptibility to dose-dependent white matter damage after brain radiotherapy. Radiother Oncol 123(2):209–217. (PMID: 10.1016/j.radonc.2017.04.006284608245518466)
David S, Mesri HY, Bodiut VA, Nagtegaal SHJ, Elhalawani H, de Luca A, et al (2019) Dose-dependent degeneration of non-cancerous brain tissue in post-radiotherapy patients: a diffusion tensor imaging study. MedRxiv 19005157.
De Langhe S (2014) Predicting normal tissue toxicity in radiotherapy: can we improve clinical decision-making? Ghent University.
Goyal H, Singh N, Gurjar OP, Tanwar RK (2020) Radiation induced demyelination in cervical spinal cord of the head and neck cancer patients after receiving radiotherapy. J Biomed Phys Eng 10(1):1.
Graham NSN (2022) Progress towards predicting neurodegeneration and dementia after traumatic brain injury. Brain.
Grossman EJ, Jensen JH, Babb JS, Chen Q, Tabesh A, Fieremans E et al (2013) Cognitive impairment in mild traumatic brain injury: a longitudinal diffusional kurtosis and perfusion imaging study. Am J Neuroradiol 34(5):951–957. (PMID: 10.3174/ajnr.A3358231796493908903)
Klistorner A, Wang C, Yiannikas C, Parratt J, Dwyer M, Barton J et al (2018) Evidence of progressive tissue loss in the core of chronic MS lesions: a longitudinal DTI study. NeuroImage Clin 17:1028–1035. (PMID: 10.1016/j.nicl.2017.12.01029387524)
Kong C, Zhu X, Lee T-F, Feng P, Xu J, Qian P et al (2016) LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma. Sci Rep 6(1):1–8.
Leemans A, Jeurissen B, Sijbers J, Jones DK (2009) ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data. In: Proc Intl Soc Mag Reson Med 3537.
Li J, Pan P, Song W, Huang R, Chen K, Shang H (2012) A meta-analysis of diffusion tensor imaging studies in amyotrophic lateral sclerosis. Neurobiol Aging 33(8):1833–1838. (PMID: 10.1016/j.neurobiolaging.2011.04.00721621298)
Liu XJ, Duan CF, Fu WW, Niu L, Li Y, Sui QL et al (2015) Correlation between magnetic resonance perfusion weighted imaging of radiation brain injury and pathology. Genet Mol Res 14(4):16317–16324. (PMID: 10.4238/2015.December.8.2326662426)
Michetti F, D’Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E et al (2019) The S100B story: from biomarker to active factor in neural injury. J Neurochem 148(2):168–187. (PMID: 10.1111/jnc.1457430144068)
Müller H-P, Kassubek J (2013) Diffusion tensor magnetic resonance imaging in the analysis of neurodegenerative diseases. JoVE (Journal Vis Exp (77):e50427.
Murugavel M, Cubon V, Putukian M, Echemendia R, Cabrera J, Osherson D et al (2014) A longitudinal diffusion tensor imaging study assessing white matter fiber tracts after sports-related concussion. J Neurotrauma 31(22):1860–1871. (PMID: 10.1089/neu.2014.3368247866664224056)
Nazem-Zadeh M-R, Chapman CH, Chenevert T, Lawrence TS, Ten Haken RK, Tsien CI et al (2014) Response-driven imaging biomarkers for predicting radiation necrosis of the brain. Phys Med Biol 59(10):2535. (PMID: 10.1088/0031-9155/59/10/2535247783644084934)
Niyazi M, Niemierko A, Paganetti H, Söhn M, Schapira E, Goldberg S et al (2020) Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. Radiother Oncol 142:154–161. (PMID: 10.1016/j.radonc.2019.09.00831563411)
Palma G, Monti S, Conson M, Pacelli R, Cella L (2019) Normal tissue complication probability (NTCP) models for modern radiation therapy. In: Seminars in Oncology. Elsevier 210–8.
Popanda O, Marquardt JU, Chang-Claude J, Schmezer P (2009) Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat Res Mol Mech Mutagen 667(1–2):58–69. (PMID: 10.1016/j.mrfmmm.2008.10.014)
Rothermundt M, Peters M, Prehn JHM, Arolt V (2003) S100B in brain damage and neurodegeneration. Microsc Res Tech 60(6):614–632. (PMID: 10.1002/jemt.1030312645009)
Song WS, Guo LB, Hong ZY, Li J-J, Wu J (2005) Serum S100 protein and radiation-induced brain injury in astrocytoma patients. Di 1 jun yi da xue xue bao= Acad J First Med Coll PLA 25(6):723–5.
Steiner J, Bogerts B, Schroeter ML, Bernstein H-G (2011) S100B protein in neurodegenerative disorders. Clin Chem Lab Med 49(3):409–424. (PMID: 10.1515/CCLM.2011.08321303299)
Stieb S, Lee A, Van Dijk LV, Frank S, Fuller CD, Blanchard P (2021) NTCP modeling of late effects for head and neck cancer: a systematic review. Int J Part Ther 8(1):95–107. (PMID: 10.14338/20-00092342859398270107)
Streitbürger D-P, Arelin K, Kratzsch J, Thiery J, Steiner J, Villringer A et al (2012) Validating serum S100B and neuron-specific enolase as biomarkers for the human brain–a combined serum, gene expression and MRI study.
Tanaka Y, Fujii M, Saito T, Kawamori J (2004) Radiation therapy for brain tumors. Nippon Igaku Hoshasen Gakkai Zasshi 64(7):387–393. (PMID: 15688744)
Verma N, Cowperthwaite MC, Burnett MG, Markey MK (2013) Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro Oncol 15(5):515–534. (PMID: 10.1093/neuonc/nos307233258633635510)
Winklewski PJ, Sabisz A, Naumczyk P, Jodzio K, Szurowska E, Szarmach A (2018) Understanding the physiopathology behind axial and radial diffusivity changes—what do we know? Front Neurol 9:92. (PMID: 10.3389/fneur.2018.00092295356765835085)
Xiang C, Zha Y, Chen Q (2018) Effect of radiotherapy and chemotherapy on levels of serum S100B, IL-6, and IL-17 in patients with malignant glioma. Eur J Inflamm 16:2058739218804329. (PMID: 10.1177/2058739218804329)
XLIIIrd Sir Peter Freyer Memorial Lecture and Surgical Symposium (2018) Irish J Med Sci (1971 -) [Internet] 187(4):115–71. Available from: https://doi.org/10.1007/s11845-018-1861-7.
Yang Z, Bai S, Gu B, Peng S, Liao W, Liu J (2015) Radiation-induced brain injury after radiotherapy for brain tumor. Mol Considerations Evol Surg Manag Issues Treat Patients with a Brain Tumor.
Yardan T, Erenler AK, Baydin A, Aydin K, Cokluk C (2011) Usefulness of S100B protein in neurological disorders. JPMA-Journal Pakistan Med Assoc 61(3):276.
فهرسة مساهمة: Keywords: Imaging biomarker; Low-grade glioma; Molecular biomarker; NTCP (normal tissue complication probability); Radiobiological modelling; Radiotherapy
المشرفين على المادة: 0 (Biomarkers)
تواريخ الأحداث: Date Created: 20230718 Date Completed: 20230925 Latest Revision: 20230925
رمز التحديث: 20240628
DOI: 10.1007/s12031-023-02136-9
PMID: 37462853
قاعدة البيانات: MEDLINE
الوصف
تدمد:1559-1166
DOI:10.1007/s12031-023-02136-9